Werling, Donna M. https://orcid.org/0000-0001-7731-0873
Brand, Harrison
An, Joon-Yong https://orcid.org/0000-0001-8839-6297
Stone, Matthew R.
Zhu, Lingxue
Glessner, Joseph T.
Collins, Ryan L. https://orcid.org/0000-0003-1268-9995
Dong, Shan
Layer, Ryan M. https://orcid.org/0000-0002-5823-3232
Markenscoff-Papadimitriou, Eirene
Farrell, Andrew
Schwartz, Grace B.
Wang, Harold Z.
Currall, Benjamin B.
Zhao, Xuefang
Dea, Jeanselle
Duhn, Clif
Erdman, Carolyn A.
Gilson, Michael C.
Yadav, Rachita
Handsaker, Robert E. https://orcid.org/0000-0002-3128-3547
Kashin, Seva
Klei, Lambertus
Mandell, Jeffrey D.
Nowakowski, Tomasz J.
Liu, Yuwen
Pochareddy, Sirisha
Smith, Louw
Walker, Michael F.
Waterman, Matthew J.
He, Xin https://orcid.org/0000-0001-9011-5212
Kriegstein, Arnold R.
Rubenstein, John L.
Sestan, Nenad https://orcid.org/0000-0003-0966-9619
McCarroll, Steven A.
Neale, Benjamin M. https://orcid.org/0000-0003-1513-6077
Coon, Hilary
Willsey, A. Jeremy
Buxbaum, Joseph D.
Daly, Mark J. https://orcid.org/0000-0002-0949-8752
State, Matthew W.
Quinlan, Aaron R. https://orcid.org/0000-0003-1756-0859
Marth, Gabor T. https://orcid.org/0000-0003-0222-1694
Roeder, Kathryn
Devlin, Bernie
Talkowski, Michael E. https://orcid.org/0000-0003-2889-0992
Sanders, Stephan J.
Article History
Received: 19 July 2017
Accepted: 6 March 2018
First Online: 26 April 2018
Competing interests
: J.L.R. is cofounder, stockholder, and currently on the scientific board of Neurona, a company studying the potential therapeutic use of interneuron transplantation. B.M.N. is an SAB member of Deep Genomics and serves as a consultant for Avanir Therapeutics. All other authors declare no competing interests.